NDC 55111-403

Zonisamide

Zonisamide

Zonisamide is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Dr. Reddy's Laboratories . The primary component is Zonisamide.

Product ID55111-403_e744c323-e44f-3dce-02c3-4faa458ec24f
NDC55111-403
Product TypeHuman Prescription Drug
Proprietary NameZonisamide
Generic NameZonisamide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2005-12-22
Marketing CategoryANDA / ANDA
Application NumberANDA077645
Labeler NameDr. Reddy's Laboratories
Substance NameZONISAMIDE
Active Ingredient Strength50 mg/1
Pharm ClassesDecreased Centr
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 55111-403-01

100 CAPSULE in 1 BOTTLE (55111-403-01)
Marketing Start Date2005-12-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55111-403-05 [55111040305]

Zonisamide CAPSULE
Marketing CategoryANDA
Application NumberANDA077645
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-12-22
Marketing End Date2010-05-31

NDC 55111-403-60 [55111040360]

Zonisamide CAPSULE
Marketing CategoryANDA
Application NumberANDA077645
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-12-22
Marketing End Date2010-05-31

NDC 55111-403-30 [55111040330]

Zonisamide CAPSULE
Marketing CategoryANDA
Application NumberANDA077645
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-12-22
Marketing End Date2010-05-31

NDC 55111-403-78 [55111040378]

Zonisamide CAPSULE
Marketing CategoryANDA
Application NumberANDA077645
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-12-22
Marketing End Date2010-05-31

NDC 55111-403-79 [55111040379]

Zonisamide CAPSULE
Marketing CategoryANDA
Application NumberANDA077645
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-09
Marketing End Date2010-05-31

NDC 55111-403-01 [55111040301]

Zonisamide CAPSULE
Marketing CategoryANDA
Application NumberANDA077645
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-12-22
Marketing End Date2010-05-31

Drug Details

Active Ingredients

IngredientStrength
ZONISAMIDE50 mg/1

Pharmacological Class

  • Decreased Central Nervous System Disorganized Electrical Activity [PE]
  • Anti-epileptic Agent [EPC]
  • Sulfonamides [CS]
  • Carbonic Anhydrase Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

NDC Crossover Matching brand name "Zonisamide" or generic name "Zonisamide"

NDCBrand NameGeneric Name
0185-0193ZonisamideZonisamide
0185-0199ZonisamideZonisamide
0185-0200ZonisamideZonisamide
0378-6725Zonisamidezonisamide
0378-6726Zonisamidezonisamide
0378-6727Zonisamidezonisamide
0615-1379Zonisamidezonisamide
0615-8266zonisamidezonisamide
21695-155ZONISAMIDEZONISAMIDE
21695-654ZONISAMIDEZONISAMIDE
29300-428ZonisamideZonisamide
29300-429ZonisamideZonisamide
29300-430ZonisamideZonisamide
31722-228ZonisamideZonisamide
33261-843ZONISAMIDEZONISAMIDE
35356-143ZONISAMIDEZONISAMIDE
43063-575Zonisamidezonisamide
43063-932ZonisamideZonisamide
50090-2174ZonisamideZonisamide
50268-816ZonisamideZonisamide
51079-768Zonisamidezonisamide
51407-137ZonisamideZonisamide
51407-138ZonisamideZonisamide
68001-243ZonisamideZonisamide
68001-242ZonisamideZonisamide
68001-244ZonisamideZonisamide
68071-4152ZonisamideZonisamide
68382-213ZonisamideZonisamide
68382-212ZonisamideZonisamide
68382-214ZonisamideZonisamide
68462-130ZonisamideZonisamide
68462-129ZonisamideZonisamide
68462-128ZonisamideZonisamide
69097-861zonisamidezonisamide
70518-1701ZonisamideZonisamide
70771-1142ZonisamideZonisamide
70771-1144ZonisamideZonisamide
70771-1143ZonisamideZonisamide
71335-0486zonisamidezonisamide
71335-0962ZonisamideZonisamide
71335-0125ZonisamideZonisamide
76282-228ZonisamideZonisamide
51407-139ZonisamideZonisamide
53217-301zonisamidezonisamide
55111-288ZonisamideZonisamide
55111-402ZonisamideZonisamide
55111-403ZonisamideZonisamide
55648-990ZONISAMIDEZONISAMIDE
55648-946ZONISAMIDEZONISAMIDE
55648-945ZONISAMIDEZONISAMIDE
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.